The company moves a step closer towards achieving its goal of emerging as the top oncology medicine supplier from India in the ASEAN region
The collaboration between CORONA and Ferring will cater to patients across India
Company intends to increase sales in the UK to approximately 2 million Euros by focusing on seven molecules which are already registered in the country
lAIH strives to introduce appropriate interventions for nurturing an AMR innovation ecosystem in the country through cohesive efforts across the innovation pyramid
The company expects the GMP approval from Saudi Food and Drug Authority (SFDA) to soon pave the way for marketing authorizations from the largest market in the GCC region
The marketing authorisations for three generic drugs signifying advances in cancer treatment will considerably benefit thousands of patients by improving access, ensuring affordability
USFDA issued issued Form 483 with nine observations, which will be addressed within stipulated time.
The company’s annual sales grew from Rs 548.12 crore in FY 2020-21 to Rs 598.65 crore this fiscal
The company dispatched the first batch of essential medicines worth US $ 30,000 to Ukraine through its embassy in New Delhi
A comprehensive assessment of the organisational systems for governance, management, operations and consistency in delivered results, this certification is an endorsement of the company's export capabilities and manufacturing prowess
Subscribe To Our Newsletter & Stay Updated
